Companies: 10,795·Total market cap: $144.5T
Alkermes plc

Alkermes plc

ALKSNASDAQHealthcare● Active
$43.37
+$0.57(+1.33%)
Market Cap$7.2B
P/E Ratio
52W High$43.69
52W Low$25.17
Overview

Alkermes plc (ALKS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALKS · as of Feb 25, 2026

Latest filing snapshot

2,050
+250+13.89%vs prior year

Alkermes plc (ALKS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
2,050
Change (1Y)
+250
Growth % (1Y)
+13.89%
Revenue / Employee
$720.0K
Net Income / Employee
$117.9K
Market Cap
$7.3B

ALKS Employee Count

2012 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-252,050+250+13.89%
2025-02-121,800-300-14.29%
2024-02-212,100-180-7.89%
2023-02-162,280+69+3.12%
2022-02-162,211-34-1.51%
2021-02-112,245+10+0.45%
2020-02-132,235-65-2.83%
2019-02-152,300+300+15.00%
2018-02-162,000+250+14.29%
2017-02-171,750+250+16.67%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Alkermes plc
ALKS
Alkermes plcYOU
2,050
#2
ACADIA Pharmaceuticals Inc.
ACAD
ACADIA Pharmaceuticals Inc.
653
#3
Arrowhead Pharmaceuticals, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
609
#4
CRISPR Therapeutics AG
CRSP
CRISPR Therapeutics AG
393
#5
Kymera Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.
208
#6
Arcellx, Inc.
ACLX
Arcellx, Inc.
163
#7
Akero Therapeutics, Inc.
AKRO
Akero Therapeutics, Inc.
69
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALKS peer comparison

About ALKS employees

ALKS Employees · Headcount

Alkermes plc (ALKS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Alkermes plc had 2,050 full-time employees globally. Full-time employees only. Global consolidated headcount.

Alkermes plc employs 2,050 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $719,951, reflecting the company's operational efficiency.

Alkermes plc's workforce increased by 250 (13.89%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Alkermes plc's revenue per employee of $719,951 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ALKS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Alkermes plc had 2,050 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Alkermes plc employee counthow many employees does Alkermes plc haveALKS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25